Skip to main content
Premium Trial:

Request an Annual Quote

Aros Offering CLC bio's Enterprise Platform for NGS Data Analysis

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danish bioinformatics firms CLC bio announced today a deal with Aros Applied Biotechnology for the use of CLC bio's enterprise platform for analyzing next-generation sequencing data.

The deal covers all steps from extraction, sample banking, and analysis to advanced bioinformatics using CLC bio's platform. Aros will now provide its customers the option to receive their data in CLC bio's format, including a time-limited license for CLC Genomics Workbench for assembly and downstream sequence analyses, CLC bio said.

Financial and other terms of the deal were not disclosed.

CLC bio and Aros are already part of a collaboration with other firms in a $5 million project for the large-scale sequence analysis of formalin-fixed, paraffin-embedded tissue samples.

Aros, based in Denmark, specializes on total genomics solutions and is GLP and GCP certified.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.